WallStreetZenWallStreetZen

NYSE: EBS
Emergent Biosolutions Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

EBS past revenue growth

How has EBS's revenue growth performed historically?
Company
-6.1%
Industry
10.18%
Market
17.2%
EBS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EBS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
EBS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

EBS earnings and revenue history

Current Revenue
$1.0B
Current Earnings
-$760.5M
Current Profit Margin
-72.5%

EBS Return on Equity

Current Company
-86.8%
Current Industry
15.4%
Current Market
188%
EBS's Return on Equity (-86.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when EBS announces earnings.

EBS Return on Assets

Current Company
-34.4%
Current Industry
3.4%
EBS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

EBS Return on Capital Employed

Current Company
-54.89%
Current Industry
5.1%
EBS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EBS vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EBS$1.05B-$518.20M-$760.50M+6.05%N/A
OPTN$70.99M-$15.55M-$35.48M+58.64%N/A
CRDL$0.00-$20.50M-$20.68M-100.00%N/A
INCR$109.73MN/A$4.29M+69.03%N/A
ETON$32.64M-$291.00k-$936.00k+141.54%N/A
View Top Pharmaceutical Stocks

EBS earnings dates

Next earnings date
May 1, 2024

Emergent Biosolutions Earnings & Revenue FAQ

What were EBS's earnings last quarter?

On Invalid Date, Emergent Biosolutions (NYSE: EBS) reported Q4 2023 earnings per share (EPS) of -$0.88, up 34.33% year over year. Total Emergent Biosolutions earnings for the quarter were -$49.50 million. In the same quarter last year, Emergent Biosolutions's earnings per share (EPS) was -$1.34.

If you're new to stock investing, here's how to buy Emergent Biosolutions stock.

What was EBS's earnings growth in the past year?

As of Q2 2024, Emergent Biosolutions's earnings has grown year over year. Emergent Biosolutions's earnings in the past year totalled -$760.50 million.

What is EBS's earnings date?

Emergent Biosolutions's earnings date is Invalid Date. Add EBS to your watchlist to be reminded of EBS's next earnings announcement.

What was EBS's revenue last quarter?

On Invalid Date, Emergent Biosolutions (NYSE: EBS) reported Q4 2023 revenue of $276.60 million up 16.23% year over year. In the same quarter last year, Emergent Biosolutions's revenue was $330.20 million.

What was EBS's revenue growth in the past year?

As of Q2 2024, Emergent Biosolutions's revenue has grown -6.1% year over year. This is 16.29 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Emergent Biosolutions's revenue in the past year totalled $1.05 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.